Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
148.39
+3.58 (2.47%)
Jan 17, 2025, 4:00 PM EST - Market closed
Krystal Biotech Employees
Krystal Biotech had 229 employees as of February 1, 2024. The number of employees increased by 19 or 9.05% compared to the previous year.
Employees
229
Change (1Y)
19
Growth (1Y)
9.05%
Revenue / Employee
$1,054,668
Profits / Employee
$228,699
Market Cap
4.27B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Feb 1, 2024 | 229 | 19 | 9.05% |
Feb 20, 2023 | 210 | 91 | 76.47% |
Feb 18, 2022 | 119 | 44 | 58.67% |
Feb 19, 2021 | 75 | 22 | 41.51% |
Feb 28, 2020 | 53 | 16 | 43.24% |
Feb 28, 2019 | 37 | 25 | 208.33% |
Jan 31, 2018 | 12 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
KRYS News
- 6 days ago - Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer - GlobeNewsWire
- 24 days ago - Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy - Seeking Alpha
- 4 weeks ago - Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer - GlobeNewsWire
- 6 weeks ago - Krystal Biotech Provides Update on EMA's Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa - GlobeNewsWire
- 7 weeks ago - Krystal Biotech to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 - GlobeNewsWire